HA

Active Director Director DIN 08674344
DIN 08674344 First appointment Jan 2020 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Hamid Ali

Data last updated:

Hamid Ali is a Director at Sacurasaq Pharmaceuticals Private Limited (since 2020). The company operates in Electrnoics. Sacurasaq Pharmaceuticals Private Limited reported revenue of ₹1.2 Lakh (FY 2023).

DIN 08674344
Primary Designation Director
Industry Electrnoics
First Appointment 21 Jan 2020
Oldest Company Age 6 yrs
Largest company Sacurasaq Pharmaceuticals Private Limited · ₹1.2 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20202020₹1.2 Lakh (FY 2023)Active

Board colleagues of Hamid Ali

NameDINCompanyDesignation
Ahmad Saqib08674345Sacurasaq Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sacurasaq Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hamid Ali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hamid Ali

Hamid Ali currently holds 1 directorship: Sacurasaq Pharmaceuticals Private Limited (Director, since 21 Jan 2020, revenue ₹1.2 Lakh (FY 2023)).

Hamid Ali was first appointed on 21 Jan 2020 as Director at Sacurasaq Pharmaceuticals Private Limited.

The current boards of Hamid Ali's companies include Ahmad Saqib (Sacurasaq Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available